---
layout: post
title: "A Risk-Based Approach To Monitoring of Clinical Investigations-Questions and Answers; Guidance for Industry; Availability"
date: 2026-02-05 18:55:11 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-07687
original_published: 2023-04-12 00:00:00 +0000
significance: 8.00
---

# A Risk-Based Approach To Monitoring of Clinical Investigations-Questions and Answers; Guidance for Industry; Availability

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** April 12, 2023 00:00 UTC
**Document Number:** 2023-07687

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "A Risk- Based Approach to Monitoring of Clinical Investigations--Questions and Answers." This guidance provides information on risk-based approaches to monitoring investigational studies of human drug and biological products, medical devices, and combination products. The guidance contains recommendations on planning a monitoring approach, developing the content of a monitoring plan, and addressing and communicating monitoring results. This guidance expands on the guidance for industry entitled "Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring" (August 2013) by providing additional information to facilitate sponsors' implementation of risk-based monitoring. This guidance finalizes the draft guidance entitled "A Risk-Based Approach to Monitoring of Clinical Investigations: Questions and Answers," issued on March 15, 2019.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/04/12/2023-07687/a-risk-based-approach-to-monitoring-of-clinical-investigations-questions-and-answers-guidance-for)
- API: https://www.federalregister.gov/api/v1/documents/2023-07687

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
